Compare Exelixis Inc. Common Stock (EXEL) vs Lucid Group Inc (LCID) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Exelixis Inc. Common Stock vs Lucid Group Inc — how do they compare? Exelixis Inc. Common Stock trades at $59.11 (market cap $14.62B), while Lucid Group Inc trades at $3.86 (market cap $1.51B). The key difference: Exelixis Inc. Common Stock is far larger — about 9.7× Lucid Group Inc's market cap, and Exelixis Inc. Common Stock is trading nearer its 52-week high, Lucid Group Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Exelixis Inc. Common Stock for 0 Days and Lucid Group Inc for 45 Days on average.
| EXEL | LCID | |
|---|---|---|
Market Cap | $14.62B | $1.51B |
Volume | 2,684,957 | 12,333,745 |
Sector | Health | Consumer Cyclical |
52-Week High | $59.13 | $21.92 |
52-Week Low | $34.54 | $3.82 |
Typical Hold Time | 0 Days | 45 Days |
Enterprise Value | $13.95B | $4.40B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Lucid Group (LCID) trades at $3.89, down 6.49% in the last session, reflecting ongoing investor concerns about the company's financial performance. The stock shows bearish technical signals with negative moving averages and faces fundamental challenges including consecutive quarterly earnings misses, negative profit margins of -249.21%, and substantial cash burn. Recent developments include strategic partnerships for autonomous vehicle deployment in Europe but also product delays and cost-cutting initiatives targeting $1.4 billion in savings.
The outlook remains challenging with significant execution risks and negative cash flow trends. While analyst consensus suggests potential upside to a $7.60 price target, the high proportion of hold ratings (66.67%) indicates caution. Key risks include continued cash burn, competitive pressures in the EV market, and execution of turnaround plans. The company's survival depends on successful cost management and timely product launches.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Exelixis Inc. Common Stock
Exelixis develops and commercializes medicines for cancer. Its research focuses on targeted therapies for oncology.
Read more on EXEL →About Lucid Group Inc
Lucid Group Inc is a technology and automotive company. It develops the next generation of electric vehicle (EV) technologies. It is a vertically integrated company that designs, engineers, and builds electric vehicles, EV powertrains, and battery systems in-house using our own equipment and factory.
Read more on LCID →
